MyFinsight
Home
Blog
About
Contact
Download
Download image
Goodwill
$10,498,539
Investment in oravax
medical
$1,500,000
Marketable securities
$3,605,508
Prepaid expenses
$1,339,503
Cash
$207,553
Total non-current
assets
$11,998,539
Total current assets
$5,152,564
Total assets
$17,151,103
Total liabilities and
stockholders equity
$17,151,103
Total mezzanine
equity
$6,323,667
Total liabilities
$5,550,149
Total stockholders
equity
$5,277,287
Convertible preferred stock
discount-Series GConvertible...
$7,544,000
Accumulated deficit
-$133,849,089
Convertible preferred stock
discount-Series FOne...
$2,065,426
Convertible preferred
stock, value-Series...
$8,737,000
Total current
liabilities
$5,550,149
Additional paid in capital
$138,952,468
Convertible preferred
stock, value-Series...
$5,130,667
Preferred stock,
value-Series DConvertible...
$144,524
Common stock, par value
0.001, 1,250,000,000...
$29,384
Convertible preferred
stock, value-Series...
$2,065,426
Dividends payable
$2,843,017
Trade and other
payables
$2,677,150
Due to mymd fl
shareholders-Related Party
$29,982
Back
Back
Balance Sheet
source: myfinsight.com
TNF Pharmaceuticals, Inc. (TNFA)
TNF Pharmaceuticals, Inc. (TNFA)